Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,644 JPY | +1.04% |
|
+2.56% | +17.01% |
Business Summary
Number of employees: 4,144
Sales per Business
JPY in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Prescription Drugs
93.1
%
| 260,235 | 93.3 % | 281,025 | 93.1 % | +7.99% |
Over-the-counter Drugs
3.7
%
| 10,628 | 3.8 % | 11,242 | 3.7 % | +5.78% |
Medical Equipment
2.6
%
| 6,257 | 2.2 % | 7,767 | 2.6 % | +24.13% |
Others
0.6
%
| 1,919 | 0.7 % | 1,931 | 0.6 % | +0.63% |
Sales per region
JPY in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Japan
58.2
%
| 177,373 | 63.6 % | 175,608 | 58.2 % | -1.00% |
EMEA
21.4
%
| 52,513 | 18.8 % | 64,756 | 21.4 % | +23.31% |
China
9.9
%
| 21,546 | 7.7 % | 29,858 | 9.9 % | +38.58% |
Asia
9.5
%
| 24,118 | 8.6 % | 28,666 | 9.5 % | +18.86% |
Americas
1.0
%
| 3,488 | 1.3 % | 3,078 | 1.0 % | -11.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Takeshi Ito
CEO | Chief Executive Officer | 64 | 82-03-31 |
Kazuo Koshiji
DFI | Director of Finance/CFO | - | - |
Akira Kurokawa
CHM | Chairman | 71 | 77-03-31 |
Mika Masunari
CMP | Compliance Officer | - | - |
Minori Hara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Investor Relations Contact | - | - | |
Keizo Nakada
PRN | Corporate Officer/Principal | - | - |
Ippei Kurihara
SAM | Sales & Marketing | - | - |
Tomoki Yashiki
HRO | Human Resources Officer | - | - |
Hiro Izaka
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Akira Kurokawa
CHM | Chairman | 71 | 77-03-31 |
Kanoko Oishi
BRD | Director/Board Member | 63 | 15-05-31 |
Noboru Kotani
BRD | Director/Board Member | 67 | 22-06-23 |
Yutaro Shintaku
BRD | Director/Board Member | 68 | 17-05-31 |
Director/Board Member | 69 | 18-05-31 | |
Takeshi Ito
CEO | Chief Executive Officer | 64 | 82-03-31 |
Tamie Minami
BRD | Director/Board Member | 65 | 22-06-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 363,996,254 | 353,052,979 ( 96.99 %) | 786,780 ( 0.2162 %) | 96.99 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
3,746,000 | 0.75% | 54,231,142 $ | |
4,594,854 | 1.26% | 47,602,044 $ | |
EISAI CO., LTD. 0.32% | 949,500 | 0.32% | 40,802,911 $ |
373,800 | 0.17% | 5,499,544 $ | |
259,040 | 0.00% | 2,733,071 $ | |
SEIKAGAKU CORPORATION 0.73% | 415,600 | 0.73% | 2,081,371 $ |
TOHO HOLDINGS CO., LTD. 0.09% | 69,050 | 0.09% | 1,744,870 $ |
SUZUKEN CO., LTD. 0.05% | 42,226 | 0.05% | 1,275,285 $ |
QD LASER, INC. 1.06% | 444,480 | 1.06% | 1,233,214 $ |
VITAL KSK HOLDINGS, INC. 0.25% | 128,474 | 0.25% | 1,108,598 $ |
Company contact information
Santen Pharmaceutical Co., Ltd.
Grand Front Osaka Tower A, 25/F 4-20 Ofuka-cho
530-8552, Osaka
+81 6 7664 8621
http://www.santen.co.jp![address Santen Pharmaceutical Co., Ltd.(4536)](https://cdn.zonebourse.com/static/address/6492071.png)
Group companies
Name | Category and Sector |
---|---|
Santen Oy
![]() Santen Oy Pharmaceuticals: MajorHealth Technology Santen Oy engages in the development, research, manufacture and marketing of pharmaceuticals, over-the-counter products, and medical devices. It specializes in ophthalmic pharmaceuticals. The company was founded on February 28, 1997 and is headquartered in Tampere, Finland. |
Pharmaceuticals: Major
|
Santen Pharmaceutical Spain SL
![]() Santen Pharmaceutical Spain SL Medical DistributorsDistribution Services Part of Santen Pharmaceutical Co., Ltd., Santen Pharmaceutical Spain SL wholesales pharmaceutical products. The company is based in Las Rozas, Spain. |
Medical Distributors
|
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.01% | 3.67B | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- 4536 Stock
- Company Santen Pharmaceutical Co., Ltd.